The "Growtropin" Company

Dong-A has been the largest pharmaceutical company in Korea since 1967.

We have solidified our leading market position on the strength of in-house developed products such as:

• Growtropin


• Evogliptin the DPP-4 inhibitor for type 2 diabetes mellitus


• Zydena Udenafil the fourth PDE5 inhibitor in the world for erectile dysfunction


• Stillen Eupatilin for herbal treatment of gastritis


• Motilitone Corydaline for functional dyspepsia

Furthermore, we are offering branded generic drugs (anti-cancer, anti-TB, etc.), bio-pharmaceutical, IMD, APIs and OTC products ensuring full compliance to international quality standard. Currently Dong-A is exporting its products to more than 50 countries to leading pharmaceutical companies in Europe, Latin America and Asia.